Less than 1 min.Read

Medlab Clinical: Recieves Australian patent for NanoCelle

September 24, 2020

Biotech company Medlab Clinical (MDC) has been granted an Australian patent for its NanoCelle delivery platform
Essentially, NanoCelle delivers drug formulations via an oral spray
So far, product testing results have indicated the spray can lead to better absorption of the drugs, helping the formulation avoid ingested routes
It can also potentially lower drug dosages and reduce the side effects of some formulations
Medlab has also filed patent applications in other jurisdictions, such as the U.S., Europe and New Zealand
On the market this afternoon, Medlab is up 3.03 per cent, trading for 17 cents per share